When it comes to knowing what bull buyers want, the Aschermanns have made it their business to be ahead of the game.
At Aschermann Charolais in Carthage, Missouri, the goal is to help commercial cattlemen raise better feeder calves by raising bulls with a reputation for calving ease, good disposition, sound feet and legs, and fescue tolerance. Both Larry and his wife, Peggy, have worked to build that reputation by using their experiences in the cattle business.
Her history is really in cattle and wheat so she provides good insight into the cattle operation about things we need to be aware of for our customers, Larry said, explaining Peggys family raised Herefords and wheat for generations in Kansas. I was born on a grain farm in Illinois and we raised hogs.
During his 4-H years, his great uncle gave him two heifers on shares Larry fed them and they split the money when they were sold and he was hooked. At the age of 13, he began to borrow money and buy cattle.
Theres nothing I like better than watching a cow have a baby calf, he said with a smile.
After attending Kansas State University and showing cattle for people to put himself through school, Larry worked as a fieldman for the American Shorthorn Association and was the first executive secretary for the American Maine-Anjou Association. He went back to Illinois and farmed for a period but quickly learned grain farming was not where his heart was. He took a position at a Monsanto subsidiary called Farmers Hybrids and worked on a program, which was developing eight proprietary composite lines of cattle for a rotational crossbreeding system.
But during that time, I became infatuated with southwest Missouri, Larry said, adding they bought an existing livestock facility and moved to the area.
Under their direction, the Four State Stockyards in Diamond grew to be one of the top livestock markets in the state. It also provided Larry with the unique perspective of seeing what worked for commercial cattlemen and what didnt.
In 1980, the area had a mixed bag of genetically diverse cows, Larry said. Later, I saw my good producers go to Angus bulls to clean up their cowherds or make them more functional.
When it came time to sell the stockyards and reenter the purebred business, he narrowed his breed choices down to Charolais. He chose the breed because Charolais-Angus cross cattle were and still are desired by feedlots and packers, he explained.
I saw a chance to moderate Charolais to where they were functional in the commercial cattle business in this part of the world and, at the same time, provide more growth and hybrid vigor, he explained, adding his confidence in crossbreeding and hybrid vigor really cemented his decision to go with Charolais cattle.
I took the breed and started modernizing them for lack of a better term through moderation, he continued. In the process, the show ring started picking the kind of cattle we were raising so we had great success in the show ring.
During the 15 years they had the stockyards, they saw the difference genetics makes in the prices received for calves due to disposition, growth or hair color.
Larry spends a lot of time on genetics, Peggy said with obvious pride in her husband. I may not have a lot of experience with geneticists but its amazing to me how he can figure out today what the cattle market is going to want and need in the future. And, truthfully, sometimes hes a little ahead of everybody else. He really is. It takes them a few years to catch up with him. But Ive never known him to be wrong, and its amazing how good he is at genetics.
Larry added tweaking the breeding and genetics of their cattle has been a long-term project. Breeding decisions today have to be what customers need years in the future when the animals are actually sold.
They have two to three generations of calving ease built into their cowherd. At the same time, they take pelvic measurements into consideration as well as calving ease. This keeps cow size in check and keeps calving ease consistent in the herd, Larry explained.
Weve worked on calving ease from the sire side but weve also done it from the cow side, he added, emphasizing they have worked diligently to develop cattle that will perform consistently for their customers.
EPDs such as calving ease and birth weight are only one of the tools they use to make breeding decisions.
A lot of the things we select for there are no EPDs, Larry said, emphasizing their focus on foot and leg soundness, fescue tolerance and eye appeal. When youre producing feeder calves that go into the sale ring and the order buyer has a minute to decide breed composition, body condition, whether they look like theyre going to feed good or not, they have to make snap decisions. So, you provide them with cattle that look the part, act the part, have the color, and have the growth.
Peggy added, Disposition is big. If Im out there by myself, I dont want to get run over by a bull.
At Aschermann Charolais, they do not spend much time trying to improve their fescue pastures but instead focus on animals that can handle the often-unimproved fescue pastures where they are expected to perform.
We dont shy away from fescue hay or pasture, Larry said. We almost insist that we grow our bulls on fescue so they are ready to go.
In addition to developing reputable lines of Charolais bulls, they have also branched out and experimented with Charolais-hybrid bulls.
Purebred breeders are, in general, innovators and tinkerers to try and make the product better, he said. We added Red Angus-Charolais crosses to our breeding program and, about five or six years ago, we started experimenting with a breed of cattle from Japan.
The introduction of purebred red Charolais, Red Angus-Charolais crosses and Akaushi crosses have allowed them to expand their offerings to commercial cattlemen who may want black calves, calves with the potential to grade Prime, or just composite bulls.
You have to have years of experience, know what your customers want, and provide what theyll pay for and what will improve their feeder calf production, he emphasized.
We try to respond to what our customers want but, right now, we think we have what they need, the cattleman continued. We try to be a one-stop shop. If you do not want a purebred Charolais, weve got some composites.
For cattlemen wanting to improve their operations, he recommended looking at their bulls.
A bulls half your herd, he said. You can have about any cow but youve got to have good bulls if youre serious about making money.
And the Aschermanns are doing their best to help those producers.
Our main business is Charolais, but we continue to try to achieve our goals of easy calving, good-footed bulls that thrive in the Four State area on the grasses that we have.
Weve bred trait leaders for the breed, he continued. Weve owned and bred cattle that win purple ribbons but our main focus is just on folks that want to raise better feeder calves.
The Aschermanns are believers in the auction system and sell bulls twice a year in sales at the ranch. Occasionally, they have their herd built up enough for a female sale but that typically doesnt take place on a regular basis.
We dont sell any bulls private treaty, he said. If youre going to come to our bull sale and buy a bull, you really dont want to buy something thats been picked over. Youd like to have the opportunity to buy the best one weve got. You may decide not to buy it but I feel like were obliged to give you the opportunity to buy the very best one.
With no private treaty sales, the semi-annual sales help them cater to customers who may have bull needs more than once a year. Bulls average 18 months in age at the sales.
The Aschermann Charolais 24th Edition Bull Sale is scheduled for March 18 at the ranch at 3852 County Road 110, Carthage, Missouri. To view the catalog or for more information, visit http://www.AschermannCharolais.com.
Original post:
Breeder focuses on genetics with goal of improving customers' feeder calves - Farm Talk
- Leveraging genetics to understand ADAR1-mediated RNA editing in health and disease - Nature - April 19th, 2025 [April 19th, 2025]
- Zevra Announces Publication of MIPLYFFA Mechanism of Action Manuscript in Molecular Genetics and Metabolism - Yahoo Finance - April 19th, 2025 [April 19th, 2025]
- Myriad Genetics price target lowered to $9 from $11 at BofA - Yahoo Finance - April 19th, 2025 [April 19th, 2025]
- Genetics of hemophilia: Why mutations matter more than ever in diagnosis and treatment - Firstpost - April 19th, 2025 [April 19th, 2025]
- RFK Jr. sparks backlash with autism comments, dismissing genetics and calling disorder preventable - 13newsnow.com - April 19th, 2025 [April 19th, 2025]
- The Crucial Role Of Genetics In Rare Diseases - BW Healthcare World - April 19th, 2025 [April 19th, 2025]
- How AI and genetics are revolutionizing psychiatric diagnosis and treatment [PODCAST] - KevinMD.com - April 10th, 2025 [April 10th, 2025]
- Opus Genetics Announces One-Month Clinical Data from Pediatric Patient in Phase 1/2 Trial of OPGx-LCA5 Gene Therapy in Inherited Retinal Diseases -... - April 10th, 2025 [April 10th, 2025]
- A genetics company just revived the dire wolf, sort of - Boy Genius Report - April 10th, 2025 [April 10th, 2025]
- Slammed 25% Opus Genetics, Inc. (NASDAQ:IRD) Screens Well Here But There Might Be A Catch - simplywall.st - April 10th, 2025 [April 10th, 2025]
- Do genetics hold the key to the US' European green crab problem? - Oceanographic Magazine - April 10th, 2025 [April 10th, 2025]
- Sequence errors are canaries in a coal mine in genetics studies, sleuth says - Retraction Watch - March 30th, 2025 [March 30th, 2025]
- Significance of noninvasive prenatal testing using massively parallel sequencing in women with twin or vanishing twin pregnancies | Journal of Human... - March 30th, 2025 [March 30th, 2025]
- All You Need to Know About Atossa Genetics (ATOS) Rating Upgrade to Buy - Yahoo Finance - March 30th, 2025 [March 30th, 2025]
- 23andMe Stock Is Surging After a Bankruptcy Judge Cleared Genetics Business Sale. Heres Why You Need to Stay Far Away From ME Shares. - Barchart - March 30th, 2025 [March 30th, 2025]
- Dairy producers leverage genetics to optimize milk composition for processing - Feedstuffs - March 30th, 2025 [March 30th, 2025]
- Several Insiders Invested In Opus Genetics Flagging Positive News - Yahoo Finance - March 30th, 2025 [March 30th, 2025]
- Human genetics and biotechnology company 23andMe to pursue bankruptcy sale after failed prepetition attempt Case Profile - ION Analytics - March 30th, 2025 [March 30th, 2025]
- AP Biology Students At NLHS Explore Genetics With Build-A-Baby Monster Lab - EastTexasRadio.com - March 30th, 2025 [March 30th, 2025]
- Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks - Yahoo Finance - March 15th, 2025 [March 15th, 2025]
- Helix Unveils Groundbreaking Real-World Insights at the ACMG Annual Clinical Genetics Meeting, Driving Clinical Care Forward - PR Newswire - March 15th, 2025 [March 15th, 2025]
- S2 Episode 3: Molecular Classification and Genetics of Endometrial Cancer - Medscape - March 15th, 2025 [March 15th, 2025]
- Fowl Play: How Chicken Genetics Barons Created the Egg Crisis - The Big Newsletter - March 15th, 2025 [March 15th, 2025]
- Exposure to violence alters human genetics for future generations - Earth.com - March 5th, 2025 [March 5th, 2025]
- Family-based genetics identifies association of CUBN IL1RL1 and PRKN variants with leprosy in Bangladesh - Nature.com - March 5th, 2025 [March 5th, 2025]
- The role of genetics in infant hearing loss: What parents need to know - The Times of India - March 5th, 2025 [March 5th, 2025]
- Analyzing Genetics May Lead to Better Contraceptive Experiences for Women - Yale School of Medicine - March 5th, 2025 [March 5th, 2025]
- Fulgent Genetics Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance - March 5th, 2025 [March 5th, 2025]
- Myriad Genetics Reports Fourth Quarter and Full-Year 2024 Financial Results; Full-year 2024 revenue of $838 million grew 11% year-over-year, the... - February 25th, 2025 [February 25th, 2025]
- Dual recombinase-mediated intersectional genetics defines the functional heterogeneity of neural stem cells in adult hippocampus - Nature.com - February 25th, 2025 [February 25th, 2025]
- Myriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to its Oncology Portfolio - Yahoo Finance - February 25th, 2025 [February 25th, 2025]
- The Genetics of Creativity: Can Creative Talent Be Inherited? - Etownian - February 25th, 2025 [February 25th, 2025]
- Weight and metabolism determined more by genetics than diet - WVTF - February 25th, 2025 [February 25th, 2025]
- Beyond genetics: The biggest factors that influence health and aging - Earth.com - February 25th, 2025 [February 25th, 2025]
- Study finds lifestyle, environment have greater impact on lifespan than genetics - CBS Boston - February 25th, 2025 [February 25th, 2025]
- 6 Things to Know About Genetics in GI Cancers - Gastroenterology & Endoscopy News - February 25th, 2025 [February 25th, 2025]
- Virologist Wendy Barclay: Wild avian viruses are mixing up their genetics all the time. Its like viral sex on steroids - The Guardian - February 3rd, 2025 [February 3rd, 2025]
- Do you find coffee too bitter? Scientists explain how your genetics and roasting process affect the flavour - Hindustan Times - February 3rd, 2025 [February 3rd, 2025]
- 2025 Illinois Performance Tested Bull Sale prioritizes trusted genetics for herd growth - Morning Ag Clips - - February 3rd, 2025 [February 3rd, 2025]
- Game-Changing Cancer Detection Tool Spots What Others Miss: New Breakthrough from SOPHiA GENETICS - StockTitan - February 3rd, 2025 [February 3rd, 2025]
- Integrative genetics and multiomics analysis reveal mechanisms and therapeutic targets in vitiligo highlighting JAK STAT pathway regulation of CTSS -... - January 23rd, 2025 [January 23rd, 2025]
- deCODE genetics: Complete recombination map of the human-genome, a major step in genetics - Financial Times - January 23rd, 2025 [January 23rd, 2025]
- Myriad Genetics Announces Hereditary Cancer Risk Assessment Program Study Published in Obstetrics & Gynecology - Yahoo Finance - January 23rd, 2025 [January 23rd, 2025]
- Bjarni V. Halldorsson and Kari Stefansson, scientists at deCODE genetics, discuss the paper: Complete recombination map of the human-genome, published... - January 23rd, 2025 [January 23rd, 2025]
- Myriad Genetics Doubles Cancer Testing Rates with Revolutionary Online Screening Tool - StockTitan - January 23rd, 2025 [January 23rd, 2025]
- Genetics, brain development, and mental health shape teen eating - News-Medical.Net - January 15th, 2025 [January 15th, 2025]
- Building Better Flu Shots Based on Antibody Responses and Genetics - Vax-Before-Travel - January 15th, 2025 [January 15th, 2025]
- Its in the Genes: Weight and Metabolism Determined by Genetics More Than Diet - Cville Right Now - January 15th, 2025 [January 15th, 2025]
- It's in the genes: Weight and metabolism determined by genetics more than diet - Medical Xpress - January 15th, 2025 [January 15th, 2025]
- Trump and Musk are obsessed with genetics but theres no science behind their simplistic views - The Guardian - January 1st, 2025 [January 1st, 2025]
- From Stonehenge's origins to ice age baby genetics how well did you follow this year's top archaeology stories? - Livescience.com - January 1st, 2025 [January 1st, 2025]
- William Thilly, MIT genetics professor who invented Apple Jacks cereal, dies at 79 - The Boston Globe - January 1st, 2025 [January 1st, 2025]
- Is Atossa Genetics (ATOS) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance - December 23rd, 2024 [December 23rd, 2024]
- With 54% ownership, Fulgent Genetics, Inc. (NASDAQ:FLGT) boasts of strong institutional backing - Yahoo Finance - December 23rd, 2024 [December 23rd, 2024]
- Using the PERC Database to Gather Insights on Epilepsy Genetics: Julie Ziobro, MD, PhD; John Schreiber, MD - Neurology Live - December 23rd, 2024 [December 23rd, 2024]
- Myriad Genetics' Breakthrough Cancer Test Named Top 10 Genomic Advance by Leading Journal - StockTitan - December 23rd, 2024 [December 23rd, 2024]
- Redecan Cannabis Launches New Limited-Edition Genetics and Expands Signature 'Wrapped & Redee' Pre-roll Line for the Holidays - Yahoo Finance - December 23rd, 2024 [December 23rd, 2024]
- Surprising yields, impressive genetics and an early harvest in 2024 Ohio Ag Net - Ohio's Country Journal and Ohio Ag Net - December 9th, 2024 [December 9th, 2024]
- Using music to help people with dementia; supporting breastfeeding radiologists; genetics and Type 2 diabetes; plus other news stories with VUMC... - December 9th, 2024 [December 9th, 2024]
- Genetics and suicideWhats the link? - Genetic Literacy Project - December 9th, 2024 [December 9th, 2024]
- Genetics is all fun and games for a Rochester card game creator - Rochester Post Bulletin - November 28th, 2024 [November 28th, 2024]
- Community engagement conduct for genetics and genomics research: a qualitative study of the experiences and perspectives of key stakeholders in Uganda... - November 28th, 2024 [November 28th, 2024]
- Dietary restriction interventions: lifespan benefits need resilience and are limited by immune compromise and genetics - Nature.com - November 28th, 2024 [November 28th, 2024]
- Texas A&M Researchers Uncover Secrets Of Horse Genetics For Conservation, Breeding - Texas A&M University Today - November 20th, 2024 [November 20th, 2024]
- Myriad Genetics Announces Prequel Prenatal Screening Can Now be Performed Eight Weeks into Pregnancy - GlobeNewswire - November 20th, 2024 [November 20th, 2024]
- Fulgent Genetics, Inc. (FLGT): Among the Best Genomics Stocks to Buy Right Now - Yahoo Finance - November 20th, 2024 [November 20th, 2024]
- Precision mutational scanning: your multipass to the future of genetics - Nature.com - November 20th, 2024 [November 20th, 2024]
- Advancements of Haploid Technology in Crops: New Horizons in Breeding and Genetics - Frontiers - November 20th, 2024 [November 20th, 2024]
- Toward advances in retinoblastoma genetics in Kenya - Nature.com - November 12th, 2024 [November 12th, 2024]
- CRISPR/Cas9 screens identify key host factors that enhance rotavirus reverse genetics efficacy and vaccine production - Nature.com - November 12th, 2024 [November 12th, 2024]
- Genetics Play Key Role in Animal Health and Welfare, Aggression and Handling - Farms.com - November 12th, 2024 [November 12th, 2024]
- Episode 174: Rudy Tanzi talks about genetics, aging and the hallmarks of Alzheimers - IHMC - October 26th, 2024 [October 26th, 2024]
- Ocuphire and Opus Genetics merge to develop IRD gene therapy - Pharmaceutical Technology - October 26th, 2024 [October 26th, 2024]
- The RD Fund Announces Ocuphire Pharma's Acquisition of Opus Genetics - PR Newswire - October 26th, 2024 [October 26th, 2024]
- The RD Fund Announces Ocuphire Pharma's Acquisition of Opus Genetics - WV News - October 26th, 2024 [October 26th, 2024]
- Faculty of Science | Protecting Canadas number one crop through genetics - UM Today - October 26th, 2024 [October 26th, 2024]
- Ocuphire and Opus Genetics merge to develop IRD gene therapy - Yahoo Finance - October 26th, 2024 [October 26th, 2024]
- Opinion | Fascinated by genetics? Where are the peas Trump made to fornicate? - The Washington Post - October 13th, 2024 [October 13th, 2024]
- Dietary restriction can extend lifespan but genetics matters more - Nature.com - October 13th, 2024 [October 13th, 2024]
- 'They have much stronger players' - Bangladesh assistant coach bizarrely blames 'genetics' for lack of six hitters in the team - Sporting News - October 13th, 2024 [October 13th, 2024]